Brevan Howard Capital Management’s Journey Medical DERM Stock Holding History

Brevan Howard Capital Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$134K	Buy	+18,857	New	+$108K	﹤0.01%	1960

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Brevan Howard Capital Management's DERM Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Journey Medical (DERM) in Q2 2026: 18,857 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #1960 among its holdings.

71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Brevan Howard Capital Management held 18,857 shares of Journey Medical worth $134K as of Q2 2026.
Journey Medical was a new Brevan Howard Capital Management position in Q2 2026.
Journey Medical made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1960 holding.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.